All lobbying filings
ORGANOGENESIS INC.
ORGANOGENESIS INC. filed a Q4 report for ORGANOGENESIS INC. on January 19, 2026.
Lobbying for ORGANOGENESIS INC.
Filing · LD-2 quarterly report
Q4 report
Reporting period
4th Quarter 2025
Oct 1 - Dec 31 · Posted Jan 19, 2026
Expenses
$300,000
What this organization spent lobbying with its own staff.
Reported using IRS section 162(e) definitions (method C): the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
Massachusetts
Government bodies contacted
2
Lobbying activity
3
Medicare reimbursement policy for chronic wound healing products, including Local Coverage Determinations Physician Fee Schedule regulations regarding reimbursement for chronic wound healing products
FDA policy on chronic wound healing products
Discussion around new company manufacturing facilities located in Smithfield, Rhode Island.